KMT2A and leukemia: MLL-CBP and MLL-ENL leukemias have distinguishable immunophenotypes with a higher percentage of MLL-ENL blasts expressing monocytic (Mac-1 and F4/80) and granulocytic (Gr-1) markers compared to MLL-CBP blasts (data not shown and Figure 2D–F).